CM

Carlo Montagner

Chief Executive Officer and Founder

Specialized Therapeutics

Therapeutic Areas

Specialized Therapeutics Pipeline

DrugIndicationPhase
NERLYNX® (neratinib)HER2-positive breast cancerCommercial